Aisling Capital Management LP Long-Term Concentrated

CIK: 0001766721 · Show all filings

Period: Q1 2024 (← Previous) (Next →)

Filing Date: May 14, 2024

Total Value ($000): $295,497 (100.0% shares, 0.0% debt)

Holdings (16)

BBIO BridgeBio Pharma Inc. (BBIO) 63.5%

Value ($000) $187,626 Shares 6,068,125 Est. Cost $40.43 Unrealized -15.9%

SNDX Syndax Pharmaceuticals, Inc. (SNDX) 8.3%

Value ($000) $24,395 Shares 1,025,000 Est. Cost $10.24 Unrealized +117.8%

— Verona Pharma plc (VRNA) 6.1%

Value ($000) $17,946 Shares 1,115,352 Est. Cost $7.38 Unrealized —

— Elevation Oncology Inc (ELEV) 4.9%

Value ($000) $14,543 Shares 2,834,910 Est. Cost $13.57 Unrealized —

BMEA Biomea Fusion Inc (BMEA) 4.0%

Value ($000) $11,941 Shares 798,757 Est. Cost $17.65 Unrealized -6.7%

GLUE Monte Rosa Therapeutics Inc (GLUE) 3.5%

Value ($000) $10,380 Shares 1,472,331 Est. Cost $20.37 Unrealized -70.9%

NUVB Nuvation Bio Inc. (NUVB) 3.1%

Value ($000) $9,249 Shares 2,541,009 Est. Cost $11.18 Unrealized -82.8%

CMPS Compass Pathways Plc (CMPS) 2.7%

Value ($000) $8,025 Shares 964,500 Est. Cost $7.40 Unrealized —

— Poseida Therapeutics Inc. (PSTX) 1.1%

Value ($000) $3,328 Shares 1,043,267 Est. Cost $8.87 Unrealized —

CALC CalciMedica, Inc. (CALC) 0.7%

Value ($000) $2,168 Shares 521,114 Est. Cost $4.55 Unrealized 0.0%

— Reneo Pharmaceuticals Inc (RPHM) 0.5%

Value ($000) $1,471 Shares 886,075 Est. Cost $9.33 Unrealized —

MRKR Marker Therapeutics, Inc. (MRKR) 0.5%

Value ($000) $1,351 Shares 314,286 Est. Cost $1.74 Unrealized +151.3%

— Avrobio, Inc. (AVRO) 0.4%

Value ($000) $1,293 Shares 1,009,779 Est. Cost $16.72 Unrealized —

— Spruce Biosciences, Inc. (SPRB) 0.3%

Value ($000) $948 Shares 1,205,511 Est. Cost $24.31 Unrealized —

ACRS Aclaris Therapeutics Inc (ACRS) 0.2%

Value ($000) $539 Shares 434,455 Est. Cost $10.31 Unrealized -88.4%

— Viracta Therapeutics Inc (VIRX) 0.1%

Value ($000) $294 Shares 288,571 Est. Cost $11.34 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
BBIO	BridgeBio Pharma Inc. (BBIO)	6,068,125	$187,626	63.5%	$40.43	-15.9%	COM	10806X102
SNDX	Syndax Pharmaceuticals, Inc. (SNDX)	1,025,000	$24,395	8.3%	$10.24	+117.8%	COM	87164F105
—	Verona Pharma plc (VRNA)	1,115,352	$17,946	6.1%	$7.38	—	SPONSORED ADS	925050106
—	Elevation Oncology Inc (ELEV)	2,834,910	$14,543	4.9%	$13.57	—	COM	28623U101
BMEA	Biomea Fusion Inc (BMEA)	798,757	$11,941	4.0%	$17.65	-6.7%	COM	09077A106
GLUE	Monte Rosa Therapeutics Inc (GLUE)	1,472,331	$10,380	3.5%	$20.37	-70.9%	COM	61225M102
NUVB	Nuvation Bio Inc. (NUVB)	2,541,009	$9,249	3.1%	$11.18	-82.8%	COM CL A	67080N101
CMPS	Compass Pathways Plc (CMPS)	964,500	$8,025	2.7%	$7.40	—	SPONSORED ADS	20451W101
—	Poseida Therapeutics Inc. (PSTX)	1,043,267	$3,328	1.1%	$8.87	—	COM	73730P108
CALC	CalciMedica, Inc. (CALC)	521,114	$2,168	0.7%	$4.55	0.0%	COM	38942Q202
—	Reneo Pharmaceuticals Inc (RPHM)	886,075	$1,471	0.5%	$9.33	—	COM	75974E103
MRKR	Marker Therapeutics, Inc. (MRKR)	314,286	$1,351	0.5%	$1.74	+151.3%	COM NEW	57055L206
—	Avrobio, Inc. (AVRO)	1,009,779	$1,293	0.4%	$16.72	—	COM	05455M100
—	Spruce Biosciences, Inc. (SPRB)	1,205,511	$948	0.3%	$24.31	—	COM	85209E109
ACRS	Aclaris Therapeutics Inc (ACRS)	434,455	$539	0.2%	$10.31	-88.4%	COM	00461U105
—	Viracta Therapeutics Inc (VIRX)	288,571	$294	0.1%	$11.34	—	COM	92765F108